Home

Mentor Labs was founded in 1997 to meet the requirements of the Greek market for bioequivalence studies. The core of business was the development, validation and utilization of assays needed for the development of new drug products by the innovator and generic pharmaceutical industry.

Since 1999 Mentor Labs has developed and validated over 60 assays and analysed over 200.000 samples across a wide range of species and matrices for human and veterinary drugs, according to EMEA and FDA guidelines.

From 2007, after 10 years of experience in clinical trials, bioequivalence and efficacy studies, Mentor Labs has expanded into conducting residue studies for veterinary medicines and in 2010 to environmental risk assessments for veterinary medicines.

Our latest activities include development of dossiers for Active Pharmaceutical Ingredients (API) and Pharmaceutical Products for both human and veterinary medicines. All studies are being conducted with co-ordination with National University of Athens and Aristotle University of Thessalonica.